News archive

More evidence for aspirin/bowel cancer prevention link

WEDNESDAY 25 JULY 2007

A new study has provided yet more evidence to support the role of aspirin in reducing the risk of bowel cancer. Several studies have suggested that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of bowel cancer by up to 40 per cent. Now, a study of osteoarthritis patients by doctors at Massachusetts General Hospital (MGH), published in the Journal of General Internal Medicine, has found that individuals with a history of osteoarthritis, for which NSAIDs are a common treatment, were 15 per cent less likely to be diagnosed with bowel cancer. Lead author Dr Elizabeth Lamont, from MGH's Cancer Centre, commented: "This is good news for people who take NSAIDs regularly for osteoarthritis. "Although patients face risks such as bleeding or kidney damage from this therapy, they probably are at a lower risk of developing colorectal (bowel) cancer." This is not the first study to find evidence for a link between aspirin use and reduced bowel cancer risk. Earlier trials have suggested that NSAIDs can protect against precancerous polyps in the bowel. Commenting on the latest research, Dr Lamont said: "The magnitude of colorectal cancer risk reduction between patients with and without osteoarthritis is completely consistent with the risk reduction for pre-cancerous polyps reported in clinical trials of NSAIDs. "Confirming this association supports the need for further research to identify NSAID agents safe enough to be used for regular, preventive therapy by the general population." Dr Lamont noted that people should not consider taking NSAIDs such as aspirin solely to prevent cancer, because of the other health risks posed by taking large doses of these drugs.

News provided by Adfero in collaboration with Cancer Research UK. Please note that all copy is © Adfero Ltd and does not reflect the views or opinions of Cancer Research UK unless explicitly stated.


* Blood test may predict breast cancer treatment response
* HPV test may offer 'better protection' than smear test
* Arsenic-based therapy may destroy leukaemia-initiating cells
* Exercise reduces the risk of breast cancer in most women
* Scientists identify genetic changes involved in childhood cancer
* Mathematical model predicts breast tumours grow faster in younger women
* Smoking death risks significantly reduced within five years of quitting
* Researchers suggest playgroups could be linked to lower leukaemia risk
* Healthy habits linked to higher quality of life among cancer survivors
* Study demonstrates drug's effect on breast cancer stem cells
A - Z index A - Z index
Contact us Contact us
Donate now Donate now
Glossary Glossary
Print this page Print this page
AddThis Feed Button

Find out more
 
 
About this site   Accessibility   Donate now   Privacy   Site Map   Terms & Conditions   Top of page

Cancer Research UK is a registered charity No. 1089464.
Registered as a company limited by guarantee in England & Wales No. 4325234.
Registered address 61 Lincoln's Inn Fields, London, WC2A 3PX.